Alder Matthias
Insider CIK 1370820 · MITI SVP, GC and Secretary · SCMP EVP, Gen. Council & Sec. · GANX Chief Operating Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 637 | — | $0 | 6,376 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 18,750 | — | $0 | 56,250 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 825 | — | $0 | 8,250 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2024-03-26 | 2024-03-28 | 637 | — | $0 | 27,225 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2024-03-26 | 2024-03-28 | 18,750 | — | $0 | 25,763 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2024-03-26 | 2024-03-28 | 825 | — | $0 | 26,588 | SEC↗ |
| GANX Gain Therapeutics, Inc. | F Tax w/h | 2024-03-26 | 2024-03-28 | 6,085 | $4.06 | $24.7K | 21,140 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 370,000 | — | $0 | 370,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | S Sale | 2023-12-21 | 2023-12-22 | 206 | $2.46 | $507 | 5,286 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2023-12-20 | 2023-12-22 | 637 | — | $0 | 7,013 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2023-12-20 | 2023-12-22 | 637 | — | $0 | 5,492 | SEC↗ |
| GANX Gain Therapeutics, Inc. | S Sale | 2023-12-07 | 2023-12-14 | 1,820 | $2.50 | $4.5K | 4,855 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2023-10-01 | 2023-10-03 | 825 | — | $0 | 9,075 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2023-10-01 | 2023-10-03 | 825 | — | $0 | 6,675 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2023-09-20 | 2023-09-22 | 2,550 | — | $0 | 7,650 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2023-09-20 | 2023-09-22 | 2,550 | — | $0 | 5,850 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2023-07-01 | 2023-07-05 | 3,300 | — | $0 | 9,900 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2023-07-01 | 2023-07-05 | 3,300 | — | $0 | 3,300 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-03-23 | 2023-03-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-03-23 | 2023-03-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 60,900 | — | $0 | 60,900 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 10,200 | — | $0 | 10,200 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 13,200 | — | $0 | 13,200 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 79,200 | — | $0 | 79,200 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2021-12-23 | 2021-12-28 | 200,000 | $5.86 | $1.17M | 200,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-30 | 2017-07-07 | 673 | $8.93 | $6.0K | 4,763 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-31 | 2017-05-10 | 641 | $9.35 | $6.0K | 4,224 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-03-06 | 2017-03-08 | 63,000 | — | $0 | 325,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-06 | 2017-03-08 | 33,000 | — | $0 | 33,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-12-31 | 2017-01-06 | 134 | $10.46 | $1.4K | 3,583 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2016-11-28 | 2016-11-28 | 24,975 | — | $0 | 262,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2016-11-28 | 2016-11-28 | 24,975 | $16.73 | $417.8K | 3,449 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2016-11-28 | 2016-11-28 | 24,975 | $8.33 | $208.0K | 28,424 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2016-11-25 | 2016-11-28 | 99,025 | — | $0 | 287,475 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2016-11-25 | 2016-11-28 | 99,025 | $15.88 | $1.57M | 3,449 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2016-11-25 | 2016-11-28 | 99,025 | $8.33 | $824.9K | 102,474 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2016-11-23 | 2016-11-28 | 26,000 | — | $0 | 386,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2016-11-23 | 2016-11-28 | 26,000 | $15.77 | $410.0K | 3,449 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2016-11-23 | 2016-11-28 | 26,000 | $8.33 | $216.6K | 29,449 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-09-30 | 2016-10-21 | 639 | $9.38 | $6.0K | 3,449 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-06-30 | 2016-07-18 | 752 | $9.32 | $7.0K | 2,810 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-03-31 | 2016-06-16 | 645 | $9.29 | $6.0K | 2,058 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2016-03-02 | 2016-03-04 | 62,500 | — | $0 | 412,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2015-12-31 | 2016-03-04 | 477 | $14.70 | $7.0K | 1,413 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2015-09-30 | 2015-11-20 | 413 | $14.52 | $6.0K | 936 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2015-06-30 | 2015-11-20 | 523 | $13.37 | $7.0K | 523 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-03-04 | 2015-11-20 | 50,000 | — | $0 | 350,000 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 66,666 | $9.25 | $616.7K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 112,500 | $5.17 | $581.6K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 135,000 | $2.92 | $394.2K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 59,375 | $7.84 | $465.5K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 50,000 | $8.44 | $422.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 8,334 | $9.25 | $77.1K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 250,000 | $7.79 | $1.95M | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 1,429 | $9.25 | $13.2K | 0 | SEC↗ |